-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

331. Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological: Poster III

Symposia: Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Noritaka Yada*, Quan Zhang*, Antonia Bignotti, B.A.*, Liang Zheng, Ph.D.*, Zhan Ye, M.D., Ph.D.* and X. Long Zheng, MD, PhD

Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS

Marina Beltrami Moreira, MD, PhD1, James B. Bussel, MD2,3 and Eun-Ju Lee, MD4

1Department of Medicine, Division of Hematology and Medical Oncology, NewYork-Presbyterian Hospital/Weill Cornell Medicine, New York, NY
2Department of Pediatrics, Division of Hematology, Weill Cornell Medicine, New York, NY
3Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
4Department of Medicne, Division of Hematology and Medical Oncology, NewYork-Presbysterian Hospital/Weill Cornell Medicine, New York, NY

Corinne Marie Lavasseur, MD1*, Rick Mathews, BE2*, Hannah Stowe McMurry, MD, MPH1*, Shira Peress, MD1*, Jean M.G. Sabile, MD1, Ileisa Oleson, BA2*, Thomas Kartika, MD3, Jamie Lo, MD4* and Joseph J Shatzel, MD5

1Department of Medicine, Oregon Health and Science University, Portland, OR
2Oregon Health and Science University School of Medicine, Portland, OR
3Hematology & Medical Oncology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York City, NY
4Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR
5Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR

Arthi Sridhar, MD1, Binoy Yohannan, MD2*, Athira Jayan, MD3*, Harmanpreet Kaur3* and Modupe Idowu, MD4,5

1Hematology and Oncology, University of Texas Health Sciences Center at Houston, Houston, TX
2Hematology and Oncology, The University of Texas Health Science Center at Houston, Houston, TX
3McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX
4Associate Professor, Medical Director, UT Physicians Comprehensive Sickle Cell Center, University of Texas Health Science Center, McGovern Medical School, Houston, TX
5University of Texas McGovern Medical School, Houston, TX

Brandon Tse1,2*, Alexandra Grudzinski2*, Michelle Kasimov2*, Michelle Sholzberg, MDCM, MSc3,4, Andrea Lausman, MD5* and Katerina Pavenski, MD, FRCPC6,7

1Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
2Hematology, St. Michael's Hospital, Toronto, ON, Canada
3Division of Hematology/Oncology, St. Michael’s Hospital, Toronto, ON, Canada
4Medicine, University of Toronto, Toronto, ON, Canada
5Department of Obstetrics and Gynecology, St. Michael’s Hospital, Toronto, ON, Canada
6St. Michael’s Hospital, Toronto, ON, Canada
7Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

Eleni Gavriilaki, MD, PhD1, Evdoxia Koravou2*, Sotiria Dimou-Mpesikli3*, Emmanouil Nikolousis, MD PhD MRCP FRCPath4*, Anastasia Banti, MD5*, Charalampos Pontikoglou, MD, PhD6*, Christina Kalpadakis7*, Aikaterini Bitsani, MD8*, Iliana Tassi, MD9*, Tasoula Touloumenidou10*, Thomas Chatzikonstantinou11*, Maria Papathanassiou12*, Antonia Syrigou13*, Eleutheria Ztriva14*, Georgia Kaiafa14*, Eudokia Mandala15*, Zois Mellios, MD16*, Dimitrios Karakasis, MD17, Alexandra Kourakli, MD, PhD18, Argyris Symeonidis19*, Eleni Kapsali, MD, PhD20, Eleni Papadaki, Prof21*, Chrysavgi Lalayanni11* and Ioanna Sakellari22*

12nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
2Department of Hematology and HCT Unit, G. Papanikolaou Hospital, Thessaloniki, Greece
3G Papanicolaou Hospital, Thessaloniki, Greece
4Hematology Department, Athens Medical Center, Athens, Greece
5Papageorgiou Hospital, Thessaloniki, AL, GRC
6Hemopoiesis Research Laboratory, School of Medicine, University of Crete and Department of Hematology, University Hospital of Heraklion, Heraklion, Greece
7Department of Haematology, University of Crete, Heraklion, Crete, GRC
8First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
9University Hospital of Ioannina, Ioannina, Greece
10Hematology Department and HCT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece
11Hematology Department – HCT Unit, George Papanicolaou Hospital, Thessaloniki, Greece
12G. Papanicolaou Hospital, Thessaloniki, GRC
13George Papanicolaou Hospital, Thessaloniki, Greece
14AHEPA Hospital, Thessaloniki, Greece
15Hippokrateion Hospital, Thessaloniki, Greece
16Department of Haematology and Lymphoma, Evangelismos General Hospital, Athens, Greece
17Evangelismos General Hospital, Department of Haematology and Bone Marrow Transplantation Unit, Athens, Greece
18Hematology Division, Department of Internal Medicine, University Hospital of Patras, Rio, Patras, Greece
19University Hospital of Patras, Patras, Greece
20Department of Hematology, University Hospital of Ioannina, Ioannina, Greece
21University of Crete, Heraklion, Greece
22Hematology Department and HCT Unit, George Papanikolaou General Hospital, THESSALONIKI, AL, Greece

Joanna Bokel, MD1*, Daniela P. Mendes-de-Almeida, MD, MSc1*, Remy Martins-Gonçalves, MSc2*, Eduarda Grinsztejn, MD3, Brenda Hoagland, MD, PhD1*, Sandra Wagner, MD, PhD1*, Kim Mattos Geraldo1*, Sandro Nazer Coutinho, BSc1*, Ingebourg Georg, PhD1*, Maria Helena Oliveira de Mello, MSc1*, Flávia dos Santos Souza, PhD1*, Alexandre G. Vizzoni, PhD1*, Valdiléa Veloso, MD, PhD1*, Patrícia T. Bozza, MD, PhD2* and Beatriz Grinsztejn, MD, PhD1*

1Instituto Nacional de Infectologia Evandro Chagas INI/FIOCRUZ, Rio de Janeiro, Brazil
2Instituto Oswaldo Cruz IOC/FIOCRUZ, Rio de Janeiro, Brazil
3Hematology-Oncology Department, University Hospitals, Case Western Reserve University, Cleveland, OH

Nonthakorn Hantrakun*, Peampost Sinsakolwat, MD*, Adisak Tantiworawit, MD, Ekarat Rattarittamrong, MD*, Thanawat Rattanathammethee, MD*, Sasinee Hantrakool, MD*, Pokpong Piriyakhuntorn, MD*, Teerachat Punnachet, MD*, Piangrawee Niprapan, MNS*, Lalita Norasetthada, MD and Chatree Chai-Adisaksopha, MD, PhD

Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Naomi Mayman, BS1*, Laura Stein, MD, MPH2*, Mandip Dhamoon, MD, DrPH, FAHA2*, John Liang, MD3*, Alexandra Reynolds, MD3* and Katherine A. Hawkins, MD4

1Icahn School of Medicine at Mount Sinai, New York, NY, New York, NY
2Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, Icahn School of Medicine at Mount Sinai, New York, NY, New York, NY
3Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, Icahn School of Medicine at Mount Sinai, New York, NY, New York, NY
4Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, New York, NY

*signifies non-member of ASH